VANCE STROMAN: Open Payments
NPI 1861189656 · CLARKSVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,491 in 63 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $901 · 2025 $1,491
Food & beverage: $1,491
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 15 | $246 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $201 |
| Novo Nordisk Inc | 8 | $146 |
| Ardelyx, Inc. | 2 | $143 |
| AstraZeneca Pharmaceuticals LP | 4 | $139 |
| PFIZER INC. | 7 | $139 |
| Lilly USA, LLC | 10 | $137 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $95 |
| CeQur Corporation | 1 | $78 |
| Astellas Pharma US Inc | 3 | $57 |
Products named: Kerendia, IBSRELA, JARDIANCE, AREXVY, TRELEGY ELLIPTA, JOURNAVX, CeQur Simplicity, BREZTRI.
Industry payments across TN — which companies pay providers there.
